Urokinase Plasminogen Activator Is Localized in Stromal Cells in Ductal Breast Cancer
- 1 November 2001
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 81 (11) , 1485-1501
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The Hallmarks of CancerCell, 2000
- Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient miceOncogene, 1998
- Cellular localisation byin situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancerBreast Cancer Research and Treatment, 1996
- Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and α2-macroglobulin receptor in human breast carcinomasInternational Journal of Cancer, 1996
- Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissuesCancer, 1996
- A time‐related study of Brefeldin A effects in HSV‐1 infected cultured human fibroblastsAPMIS, 1995
- Clinical Relevance of the Urokinase-Type and Tissue-Type Plasminogen Activators and of Their Type 1 Inhibitor in Breast CancerSeminars in Thrombosis and Hemostasis, 1991
- Immunohistochemical Localization of Urokinase- and Tissue-Type Plasminogen Activators in Psoriatic SkinJournal of Investigative Dermatology, 1987
- Enzyme-Linked Immunosorbent Assay for Human Urokinase-Type Plasminogen Activator and its Proenzyme Using a Combination of Monoclonal and Polyclonal AntibodiesJournal of Immunoassay, 1986
- Human endothelial cells contain one type of plasminogen activatorFEBS Letters, 1984